- Interleukin-17A Antagonist
- Accession Number
- DBCAT003508 (DBCAT004179)
Drug Drug Description Secukinumab An immunomodulating agent and interleukin antagonist used to manage plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders. Ixekizumab A monoclonal antibody used to treat moderate to severe plaque psoriasis.
- Drugs & Drug Targets
Drug Target Type Secukinumab Interleukin-17A target Ixekizumab Interleukin-17A target